Butylated hydroxyanisole specifically inhibits tumor necrosis factor-induced cytotoxicity and growth enhancement

This publication has 27 references indexed in Scilit:

• Cytokine regulation of interleukin 6 production by human endothelial cells
  Cellular Immunology, 1989
• Interleukin-one induced inositol phospholipid breakdown in murine macrophages: Possible mechanism of receptor activation
  Biochemical and Biophysical Research Communications, 1988
• Reduced tumour necrosis factor-induced cytotoxicity by inhibitors of the arachidonic acid metabolism
  Biochemical and Biophysical Research Communications, 1987
• Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection.
  The Journal of Experimental Medicine, 1987
• ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASE
  The Lancet, 1987
• Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors.
  The Journal of Experimental Medicine, 1986
• Recombinant Human Tumor Necrosis Factor-α: Effects on Proliferation of Normal and Transformed Cells in Vitro
  Science, 1985
• Factors influencing endothelial cell proliferation in vitro
  Journal of Cellular Physiology, 1978
• Inhibition of the mono-oxygenase system by butylated hydroxyanisole and butylated hydroxytoluene
  Life Sciences, 1974
• The inhibition of the fatty acid oxygenase of sheep vesicular gland by antioxidants
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1973